A Single-Centre, Single-Blind, Randomised, Placebo-Controlled, Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics After Single Ascending Intravenous Doses of AZD1305 in Healthy Male Japanese Subjects.
Phase of Trial: Phase I
Latest Information Update: 01 Jul 2009
At a glance
- Drugs AZD 1305 (Primary)
- Indications Arrhythmias; Atrial fibrillation; Atrial flutter; Left ventricular dysfunction
- Focus Adverse reactions
- 01 Jul 2009 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
- 01 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Sep 2008 New trial record.